VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

6 superinvestors reported owning VRX (Common Stock) according to the gurus' 2013 Q2 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The top 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Glenn Greenberg - Brave Warrior Advisors (26.53%), Jeffrey Ubben - ValueAct Holdings (16.74%), Ole Andreas Halvorsen - Viking Global Investors (4.54%), Quincy Lee - Ancient Art (Teton Capital) (3.56%) and Stephen Mandel - Lone Pine Capital (3.48%) as of their 2013 Q2 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2013 Q2" dropdown menu and select the date.

# of holders: 6
Period: 2013 Q2
Type: Common Stock
History
Name
Company
% of
Portfolio
Shares*
Price*
Value
% (shares)
Activity
% change to
Portfolio
Glenn Greenberg
Brave Warrior Advisors
26.53%
6,657,451
$86.08
$573,073,000
buy or own*
+26.53%
Jeffrey Ubben
ValueAct Holdings
16.74%
18,923,877
$86.08
$1,628,967,000
buy or own*
+16.74%
Nathaniel Simons
Meritage Group
3.46%
1,185,229
$86.08
$102,025,000
buy or own*
+3.46%
Ole Andreas Halvorsen
Viking Global Investors
4.54%
9,492,256
$86.08
$817,093,000
buy or own*
+4.54%
Quincy Lee
Ancient Art (Teton Capital)
3.56%
151,295
$86.08
$13,023,000
buy or own*
+3.56%
Stephen Mandel
Lone Pine Capital
3.48%
8,012,507
$86.08
$689,717,000
buy or own*
+3.48%
AVG reported hold price*: $86.08

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Buy or own - this means there is no earlier reporting (for us or in general).
So we can't know if the actual purchase of the security happened at the reported period or earlier.